middle.news
BlinkLab Nears FDA Milestone with Autism and ADHD Trials Expansion
8:48am on Friday 25th of July, 2025 AEST
•
Healthcare
Read Story
BlinkLab Nears FDA Milestone with Autism and ADHD Trials Expansion
8:48am on Friday 25th of July, 2025 AEST
Key Points
163 children completed U.S. autism pilot trial; main phase to start soon
European ADHD trial expanded to five sites, targeting 300 participants
U.S. IRB approval secured for main FDA study phase
$7.66 million capital raised to fund clinical and regulatory programs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blinklab (ASX:BB1)
OPEN ARTICLE